These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

708 related items for PubMed ID: 18356456

  • 1. Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue.
    Wiginton CD, Kelly B, Oto A, Jesse M, Aristimuno P, Ernst R, Chaljub G.
    AJR Am J Roentgenol; 2008 Apr; 190(4):1060-8. PubMed ID: 18356456
    [Abstract] [Full Text] [Related]

  • 2. Nephrogenic systemic fibrosis: possible association with a predisposing infection.
    Golding LP, Provenzale JM.
    AJR Am J Roentgenol; 2008 Apr; 190(4):1069-75. PubMed ID: 18356457
    [Abstract] [Full Text] [Related]

  • 3. A preclinical study to investigate the development of nephrogenic systemic fibrosis: a possible role for gadolinium-based contrast media.
    Sieber MA, Pietsch H, Walter J, Haider W, Frenzel T, Weinmann HJ.
    Invest Radiol; 2008 Jan; 43(1):65-75. PubMed ID: 18097279
    [Abstract] [Full Text] [Related]

  • 4. Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study.
    Kallen AJ, Jhung MA, Cheng S, Hess T, Turabelidze G, Abramova L, Arduino M, Guarner J, Pollack B, Saab G, Patel PR.
    Am J Kidney Dis; 2008 Jun; 51(6):966-75. PubMed ID: 18501784
    [Abstract] [Full Text] [Related]

  • 5. Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis.
    Abraham JL, Thakral C, Skov L, Rossen K, Marckmann P.
    Br J Dermatol; 2008 Feb; 158(2):273-80. PubMed ID: 18067485
    [Abstract] [Full Text] [Related]

  • 6. Nephrogenic systemic fibrosis: center case review.
    Lauenstein TC, Salman K, Morreira R, Tata S, Tudorascu D, Baramidze G, Singh-Parker S, Martin DR.
    J Magn Reson Imaging; 2007 Nov; 26(5):1198-203. PubMed ID: 17969162
    [Abstract] [Full Text] [Related]

  • 7. Nephrogenic systemic fibrosis: a report of 29 cases.
    Shabana WM, Cohan RH, Ellis JH, Hussain HK, Francis IR, Su LD, Mukherji SK, Swartz RD.
    AJR Am J Roentgenol; 2008 Mar; 190(3):736-41. PubMed ID: 18287446
    [Abstract] [Full Text] [Related]

  • 8. Nephrogenic systemic fibrosis: risk factors and incidence estimation.
    Sadowski EA, Bennett LK, Chan MR, Wentland AL, Garrett AL, Garrett RW, Djamali A.
    Radiology; 2007 Apr; 243(1):148-57. PubMed ID: 17267695
    [Abstract] [Full Text] [Related]

  • 9. Nephrogenic systemic fibrosis: change in incidence following a switch in gadolinium agents and adoption of a gadolinium policy--report from two U.S. universities.
    Altun E, Martin DR, Wertman R, Lugo-Somolinos A, Fuller ER, Semelka RC.
    Radiology; 2009 Dec; 253(3):689-96. PubMed ID: 19789233
    [Abstract] [Full Text] [Related]

  • 10. Nephrogenic systemic fibrosis after gadopentetate dimeglumine exposure: case series of 36 patients.
    Abujudeh HH, Kaewlai R, Kagan A, Chibnik LB, Nazarian RM, High WA, Kay J.
    Radiology; 2009 Oct; 253(1):81-9. PubMed ID: 19709997
    [Abstract] [Full Text] [Related]

  • 11. Incidence of nephrogenic systemic fibrosis at two large medical centers.
    Prince MR, Zhang H, Morris M, MacGregor JL, Grossman ME, Silberzweig J, DeLapaz RL, Lee HJ, Magro CM, Valeri AM.
    Radiology; 2008 Sep; 248(3):807-16. PubMed ID: 18710976
    [Abstract] [Full Text] [Related]

  • 12. Nephrogenic systemic fibrosis is found only among gadolinium-exposed patients with renal insufficiency: a case-control study from Denmark.
    Elmholdt TR, Pedersen M, Jørgensen B, Søndergaard K, Jensen JD, Ramsing M, Olesen AB.
    Br J Dermatol; 2011 Oct; 165(4):828-36. PubMed ID: 21692765
    [Abstract] [Full Text] [Related]

  • 13. Application of gadolinium-based contrast agents and prevalence of nephrogenic systemic fibrosis in a cohort of end-stage renal disease patients on hemodialysis.
    Becker S, Walter S, Witzke O, Kreuter A, Kribben A, Mitchell A.
    Nephron Clin Pract; 2012 Oct; 121(1-2):c91-4. PubMed ID: 23182840
    [Abstract] [Full Text] [Related]

  • 14. Risk of nephrogenic systemic fibrosis: evaluation of gadolinium chelate contrast agents at four American universities.
    Wertman R, Altun E, Martin DR, Mitchell DG, Leyendecker JR, O'Malley RB, Parsons DJ, Fuller ER, Semelka RC.
    Radiology; 2008 Sep; 248(3):799-806. PubMed ID: 18632533
    [Abstract] [Full Text] [Related]

  • 15. Nephrogenic systemic fibrosis: a review of 6 cases temporally related to gadodiamide injection (omniscan).
    Khurana A, Runge VM, Narayanan M, Greene JF, Nickel AE.
    Invest Radiol; 2007 Feb; 42(2):139-45. PubMed ID: 17220732
    [Abstract] [Full Text] [Related]

  • 16. High prevalence of nephrogenic systemic fibrosis in chronic renal failure patients exposed to gadodiamide, a gadolinium-containing magnetic resonance contrast agent.
    Rydahl C, Thomsen HS, Marckmann P.
    Invest Radiol; 2008 Feb; 43(2):141-4. PubMed ID: 18197066
    [Abstract] [Full Text] [Related]

  • 17. Multiorgan gadolinium (Gd) deposition and fibrosis in a patient with nephrogenic systemic fibrosis--an autopsy-based review.
    Sanyal S, Marckmann P, Scherer S, Abraham JL.
    Nephrol Dial Transplant; 2011 Nov; 26(11):3616-26. PubMed ID: 21441397
    [Abstract] [Full Text] [Related]

  • 18. A follow-up of four cases of nephrogenic systemic fibrosis: is gadolinium the specific trigger?
    Singh M, Davenport A, Clatworthy I, Lewin J, Deroide F, Hubbard V, Rustin MH.
    Br J Dermatol; 2008 Jun; 158(6):1358-62. PubMed ID: 18363754
    [Abstract] [Full Text] [Related]

  • 19. Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort.
    Collidge TA, Thomson PC, Mark PB, Traynor JP, Jardine AG, Morris ST, Simpson K, Roditi GH.
    Radiology; 2007 Oct; 245(1):168-75. PubMed ID: 17704357
    [Abstract] [Full Text] [Related]

  • 20. Quantification of gadolinium in nephrogenic systemic fibrosis: re-examination of a reported cohort with analysis of clinical factors.
    Khurana A, Greene JF, High WA.
    J Am Acad Dermatol; 2008 Aug; 59(2):218-24. PubMed ID: 18538448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.